Mancare Laboratories Plans New Pharmaceutical Manufacturing Unit in Selaqui

Mancare Laboratories Private Limited

Mancare Laboratories Pvt. Ltd., already operating Unit 1 in Pharmacity, Selaqui with valid UKPCB consent, is expanding its operations. The company is setting up Unit 2 in Sara Industrial Area, Phase-II, with ongoing construction after receiving EC from SEIAA and Consent to Establish from UKPCB. To meet the rising demand for tablets, capsules, dry syrup, and dry injection, Mancare is now planning a new Unit 3 in Selaqui Industrial Area, Dehradun, for manufacturing pharmaceutical products.

Location:  Dehradun Uttarakhand

Estimated Value (Rs. Cr): 8

Sector: Drugs/Pharma

Project Stage: Conceptual/Planning

Contact Details: You need to be a paid subscriber to get these details. Contacts are available in the ProjectX India – 1st November 2024 PDF Edition.

Click here to buy this copy for Rs 469 only or go for an annual subscription.

#New-Projects-In-India-1st November 2024-101

*Image used in this post if any is for illustration only


What are the upcoming Drugs/Pharma projects in India?

Access Drugs/Pharma sector projects in India

Stay ahead in the world of Construction Projects, Industrial Projects, and Infrastructure Projects with ProjectX India’s exclusive fortnightly editions. Your trusted source for the latest consultancy opportunities, we deliver essential updates on upcoming and ongoing projects across sectors, including construction, industrial, steel, ethanol, pharmaceuticals, and chemicals. Gain exclusive access to project trackers, contract awards, and tenders that can drive your business forward. Subscribe today to stay connected with actionable project insights and key contacts, empowering you to succeed in India’s dynamic project landscape.

Click here to download a sample evaluation copy: Explore New Projects, Ongoing Projects, Contract Awards, and Public Procurement Opportunities in India.

For subscriptions or buying this edition, you can Whatsapp us at +91 877 927 9155 or click here.